KVP Capital Advisors »

Tango Therapeutics shares owned by KVP Capital Advisors

Quarter-by-quarter ownership of Tango Therapeutics (TNGX) shares owned by KVP Capital Advisors from 13F filings

Historical chart of KVP Capital Advisors investment in Tango Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tango Therapeutics held by KVP Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tango Therapeutics by KVP Capital Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $4.8M 230k 20.92

More positions owned by KVP Capital Advisors

Terns Pharmaceuticals (TERN)
Praxis Precision Medicines I Com New (PRAX)
Aadi Bioscience (WHWK)
Axsome Therapeutics (AXSM)
Sutro Biopharma Com Shs (STRO)
Protagonist Therapeutics (PTGX)
Erasca (ERAS)
Trevi Therapeutics (TRVI)
Tango Therapeutics (TNGX)
Insmed Com Par $.01 (INSM)
Edgewise Therapeutics (EWTX)
Revolution Medicines (RVMD)
Disc Medicine (IRON)
Mbx Biosciences (MBX)
Savara (SVRA)

View all positions for KVP Capital Advisors

Top funds holding Tango Therapeutics

Farallon Capital Management
Boxer Capital Management
Adage Capital Partners GP
TCG Crossover Management
BlackRock
Siren
Woodline Partners
Nextech Invest
Vanguard Group
Trv Gp Iv
State Street Corporation
Vanguard Capital Management
Goldman Sachs Group
Deerfield Management Company
Paradigm Biocapital Advisors

View all funds holding Tango Therapeutics